HomePMCB • NASDAQ
add
Pharmacyte Biotech Inc
Previous close
$1.52
Year range
$1.39 - $2.58
Market cap
10.59M USD
Avg Volume
14.50K
P/E ratio
1.71
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.11M | -21.53% |
Net income | -1.47M | -152.67% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.84M | -71.62% |
Total assets | 55.10M | -30.15% |
Total liabilities | 11.65M | -32.64% |
Total equity | 43.45M | — |
Shares outstanding | 7.03M | — |
Price to book | 0.25 | — |
Return on assets | -4.41% | — |
Return on capital | -5.73% | — |
Cash Flow
Net change in cash
| (USD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -1.47M | -152.67% |
Cash from operations | -1.05M | 46.85% |
Cash from investing | 0.00 | — |
Cash from financing | -10.74M | -1,534.56% |
Net change in cash | -11.80M | -853.32% |
Free cash flow | -3.64M | -298.03% |
About
Founded
1996
Headquarters
Website
Employees
2
